A woman from Rhineland-Palatinate will face trial at the Frankenthal Regional Court on Tuesday, accused of health damage caused by a coronavirus vaccination from Biontech. The lawsuit alleges that a second vaccination resulted in a bilateral pulmonary artery embolism, or blocked blood vessels in the lungs. However, the cause remains undetermined, leading the woman to attribute the issue to the vaccine.
Claiming damages and compensation for pain and suffering, the woman has sued Biontech. The pharmaceutical giant, in turn, considers the claim unfounded. Both parties have been summoned to the court for a potential settlement discussion. Further trial dates have yet to be decided.
This trial is not the first of its kind in Germany. Previous lawsuits focused on alleged vaccine damage have already been dismissed. Despite this, the woman is persisting in her pursuit of justice.
The trial was initially set for October 10 but had to be postponed due to the illness of a party involved. The trial's outcome may influence public perception of the pharmaceutical industry and the COVID-19 vaccination in Germany, as vaccine damage remains a contentious topic.
Incorporating recent insights from medical and legal fields, it's worth noting that the correlation between vaccines and severe side effects is under ongoing investigation. Some studies suggest that specific risk factors, such as pre-existing medical conditions or medication usage, might contribute to the perceived vaccine-related harm. On the other hand, trust in vaccines is crucial to combat the ongoing spread of COVID-19 and other diseases, so it's essential to approach these cases with care and caution.
Sources: (Base Article) & (used sparingly, approximately 15%)
